A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

Summary

The main purpose of the dose escalation phase of the study is to determine the safety of different doses of OMX-0407. The dose expansion (phase Ib) part of the study will evaluate efficacy, safety and tolerability at a dose determined in the dose escalation,

Timeline

Start

2023-03-30

Primary completion

2026-04-02

Completion

2026-04-02

Outcome

Outcome not reported

Stopped (Business): “Study terminated as part of strategic considerations and not based on safety concerns.”

Drugs

Indications